Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HT KIT

Next Previous
X
Search
Drug Profile

HT KIT

Alternative Names: HT-KIT mRNA Frame Shifting Therapeutic

Latest Information Update: 01 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator North Carolina State University
  • Developer Hoth Therapeutics
  • Class Antineoplastics; Antisense oligonucleotides; Morpholines; Skin disorder therapies
  • Mechanism of Action Proto-oncogene protein c-kit expression inhibitors; RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Mastocytosis
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Anaphylaxis; Leukaemia; Mastocytosis

Most Recent Events

  • 29 Oct 2024 Pharmacodynamics data from preclinical trial in Mastocytosis released by Hoth Therapeutics
  • 14 Nov 2023 US FDA completes pre-IND meeting for HIT KIT in Mastocytosis
  • 02 Oct 2023 Hoth Therapeutics anticipates a pre-IND meeting with the US FDA in November 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top